Literature DB >> 26464281

Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.

Daniel Steil1, Catherine-Louise Schepers1, Gottfried Pohlentz1, Nadine Legros1, Jana Runde2, Hans-Ulrich Humpf2, Helge Karch1, Johannes Müthing3.   

Abstract

Shiga toxins (Stxs) are produced by enterohemorrhagic Escherichia coli (EHEC), which cause human infections with an often fatal outcome. Vero cell lines, derived from African green monkey kidney, represent the gold standard for determining the cytotoxic effects of Stxs. Despite their global use, knowledge about the exact structures of the Stx receptor glycosphingolipids (GSLs) and their assembly in lipid rafts is poor. Here we present a comprehensive structural analysis of Stx receptor GSLs and their distribution to detergent-resistant membranes (DRMs), which were prepared from Vero-B4 cells and used as lipid raft equivalents. We identified globotriaosylceramide (Gb3Cer) and globotetraosylceramide (Gb4Cer) as the GSL receptors for Stx1a, Stx2a, and Stx2e subtypes using TLC overlay detection combined with MS. The uncommon Stx receptor, globopentaosylceramide (Gb5Cer, Galβ3GalNAcβ3Galα4Galβ4Glcβ1Cer), which was specifically recognized (in addition to Gb3Cer and Gb4Cer) by Stx2e, was fully structurally characterized. Lipoforms of Stx receptor GSLs were found to mainly harbor ceramide moieties composed of sphingosine (d18:1) and C24:0/C24:1 or C16:0 fatty acid. Moreover, co-occurrence with lipid raft markers, SM and cholesterol, in DRMs suggested GSL association with membrane microdomains. This study provides the basis for further exploring the functional impact of lipid raft-associated Stx receptors for toxin-mediated injury of Vero-B4 cells.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Shiga toxin-producing Escherichia coli; enterohemorrhagic Escherichia coli; globo-series; globopentaosylceramide; glycolipids; lysophospholipids; mass spectrometry; microdomains; phospholipids; sphingolipids

Mesh:

Substances:

Year:  2015        PMID: 26464281      PMCID: PMC4655988          DOI: 10.1194/jlr.M063040

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  100 in total

1.  Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells.

Authors:  Andreas Bauwens; Martina Bielaszewska; Björn Kemper; Patrik Langehanenberg; Gert von Bally; Rudolf Reichelt; Dennis Mulac; Hans-Ulrich Humpf; Alexander W Friedrich; Kwang S Kim; Helge Karch; Johannes Müthing
Journal:  Thromb Haemost       Date:  2010-12-06       Impact factor: 5.249

Review 2.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

3.  Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation.

Authors:  Wiebke Storck; Iris Meisen; Kathrin Gianmoena; Ina Pläger; Ivan U Kouzel; Martina Bielaszewska; Jörg Haier; Michael Mormann; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  Biol Chem       Date:  2012-08       Impact factor: 3.915

4.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.

Authors:  Christian H Schweppe; Petra Hoffmann; Jerzy-Roch Nofer; Gottfried Pohlentz; Michael Mormann; Helge Karch; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

5.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.

Authors:  T Ohkusa; I Okayasu; T Ogihara; K Morita; M Ogawa; N Sato
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 6.  Shiga Toxin (Verotoxin)-Producing Escherichia coli in Japan.

Authors:  Jun Terajima; Sunao Iyoda; Makoto Ohnishi; Haruo Watanabe
Journal:  Microbiol Spectr       Date:  2014-10

Review 7.  Sphingomyelin and its role in cellular signaling.

Authors:  Mahua Chakraborty; Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 8.  The role of glycosphingolipid metabolism in the developing brain.

Authors:  Robert K Yu; Yoshihiko Nakatani; Makoto Yanagisawa
Journal:  J Lipid Res       Date:  2008-10-09       Impact factor: 5.922

9.  Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype.

Authors:  A Pudymaitis; G Armstrong; C A Lingwood
Journal:  Arch Biochem Biophys       Date:  1991-05-01       Impact factor: 4.013

10.  Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.

Authors:  G T Keusch; M Jacewicz; D W Acheson; A Donohue-Rolfe; A V Kane; R H McCluer
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  15 in total

1.  Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Methods Mol Biol       Date:  2021

2.  Mass spectrometry imaging to explore molecular heterogeneity in cell culture.

Authors:  Tanja Bien; Krischan Koerfer; Jan Schwenzfeier; Klaus Dreisewerd; Jens Soltwisch
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-11       Impact factor: 12.779

3.  Separation of glycosphingolipids with titanium dioxide.

Authors:  Ayaka Noda; Miki Kato; Shota Miyazaki; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2018-10-04       Impact factor: 2.916

4.  Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.

Authors:  Nadine Legros; Gottfried Pohlentz; Daniel Steil; Ivan U Kouzel; Ivan Liashkovich; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2018-06-04       Impact factor: 5.922

5.  Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Julia S Schmitz; Daniel Steil; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2017-10-25       Impact factor: 4.546

Review 6.  Biological roles of glycans.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

7.  CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.

Authors:  Alline R Pacheco; Jacob E Lazarus; Brandon Sit; Stefanie Schmieder; Wayne I Lencer; Carlos J Blondel; John G Doench; Brigid M Davis; Matthew K Waldor
Journal:  mBio       Date:  2018-06-19       Impact factor: 7.867

Review 8.  Roles of Shiga Toxins in Immunopathology.

Authors:  Moo-Seung Lee; Vernon L Tesh
Journal:  Toxins (Basel)       Date:  2019-04-09       Impact factor: 4.546

Review 9.  Escherichia coli Shiga Toxins and Gut Microbiota Interactions.

Authors:  Kyung-Soo Lee; Yu-Jin Jeong; Moo-Seung Lee
Journal:  Toxins (Basel)       Date:  2021-06-11       Impact factor: 4.546

Review 10.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.